In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes

Journal of Microbiology

Volumn 45, Issue 5, 2007, Pages 473-477

  Lim, Young Hee ^a   Kim, In Hwan ^a   Seo, Jung Ju ^b  

^a Korea University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Checkerboard test; Clindamycin; Erythromycin; Kaempferol; Propionibacterium acnes

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; KAEMPFEROL; KAEMPFEROL DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; GROWTH, DEVELOPMENT AND AGING; IMPATIENS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; PROPIONIBACTERIUM ACNES;

AMPICILLIN; CHLORAMPHENICOL; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; ERYTHROMYCIN; IMPATIENS; KAEMPFEROLS; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; TETRACYCLINE;

IMPATIENS; IMPATIENS BALSAMINA; PROPIONIBACTERIUM ACNES;

EID: 35648995463     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Arima, H., H. Ashida, and G. Danno. 2002. Rutin-enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci. Biotechnol Biochem. 66, 1009-1014.
2. Bialecka, A., M. Mak, R. Biedroń, M. Bobek, A. Kasprowicz, and J. Marcinkiewicz. 2005. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne. Arch. Immunol. Ther. Exp. 53, 79-85.
3. Bojar, R.A. and K.T. Holland. 2004. Acne and Propionibacterium acnes. Clin. Dermatol. 22, 375-379.
4. Chivot, M. 2005. Retinoid therapy for acne. Am. J. Clin. Dermatol. 6, 13-19.
5. Coates, P., S. Vyakrnam, E.A. Eady, C.E. Jones, J.H. Cove, and W.J. Cunliffe. 2002. Prevalence of antibiotic-resistant propioni-bacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br. J. Dermatol. 146, 840-848.
6. Eady, E.A., M. Gloor, and J.J. Leyden. 2003. Propionibacterium acnes resistance: A world problem. Dermatology 206, 54-56.
7. Eady, E.A. and E. Ingham. 1994. Propionibacterium acnes-friend of foe? Rev. Med. Microbiol. 5, 163-173.
8. Gould, I.M. and K. Milne. 1997. In vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. J. Antimicrob. Chemother. 39, 53-61.
9. Jung, H.J., K.S. Choi, and D.G. Lee. 2005. Synergistic killing effect of synthetic peptide P20 and cefotaxime on methicillin-resistant nosocomial isolates of Staphylococcus aureus. J. Microbiol. Biotechnol 15, 1039-1046.
10. Kang, S.C. and Y. Moon. 1992. Isolation and antimicrobial activity of a naphthoquinone from Impatiens balsamina. Saengyak Hakhoechi 23, 240-247.
11. Krautheim, A. and H.P.M. Gollnick. 2004. Acne: Topical treatment. Clin. Dermatol. 22, 398-407.
12. Lee, J., E. Jung, J. Park, K. Jung, S. Lee, S. Hong, J. Park, E. Park, J. Kim, S. Park, and D. Park. 2005. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-κB activation signaling. Planta. Med. 71, 338-343.
13. Liang, Y.C., Y.T. Huang, S.H. Tsai, S.Y. Shiau, C.F. Chen, and J.K. Lin. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20, 1945-1952.
14. Lim, Y.H., I.H. Kim, J.J. Seo, and J.K. Kim. 2006. Tyrosinase inhibitor from the flowers of Impatiens balsamina. J. Microbiol. Biotechnol. 16, 1977-1983.
15. Lin, R.D., Y.P. Chin, and M.H. Lee. 2005. Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae. Phytother. Res. 19, 612-617.
16. Mayer, I. and E. Nagy. 1999. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.. J. Antimicrob. Chemother. 43, 651-657.
17. Meltz, M.L. and J.T. MacGregor. 1981. Activity of the plant flavonol quercetin in the mouse lymphoma L5178Y TK+/- mutation, DNA single-strand break, and Balb/c 3T3 chemical transformation assays. Mutat. Res. 88, 317-324.
18. National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria: Tentative Standard M11-A4. National Committee for Clinical Laboratory Standards, Villanova, PA, USA.
19. Oprica, C. and C.E. Nord. 2005. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin. Microbiol Infect. 11, 204-213.
20. Pillai, S.K., R.C. Moellering, and G.M. Eliopoulos. 2005. Antimicrobial combinations, p. 365-440. In V. Lorian (ed.), Antibiotics in Laboratory Medicine. Lippincott Williams & Wilkins, PA, USA.
21. Ross, J.I., A.M. Snelling, E. Carnegie, P. Coates, W.J. Cunliffe, V. Bettoli, G. Tosti, A. Katsambas, J.I.G. Pulgar, O. Rollman, L. Török, E.A. Eady, and J.H. Cove. 2003. Antibiotic-resistant acne: lessons from Europe. Br. J. Dermatol. 148, 467-478.
22. Shannon, B.A., K.L. Garrett, and R.J. Cohen. 2006. Links between Propionibacterium acnes and prostate cancer. Future Oncol. 2, 225-232.
23. Sobieszczyk, M.E., E.Y. Furuya, C.M. Hay, P. Pancholi, P. Della-Latta, S.M. Hammer, and C.J. Kubin. 2004. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. J. Antimicrob. Chemother. 54, 566-569.
24. Sung, W.S., H.J. Jung, I.S. Lee, H.S. Kim, and D.G. Lee. 2006. Antimicrobial effect of furaneol against human pathogenic bacteria and fungi. J. Microbiol Biotechnol 16, 349-354.
25. Viluksela, M., P.J. Vainio, and R.K. Tuominen. 1996. Cytotoxicity of macrolide antibiotics in a cultured human liver cell line. J. Antimicrob. Chemother. 38, 465-473.
26. Vowels, B.R., S. Yang, and L.L. Leyden. 1995. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect. Immun. 63, 3158-3165.
27. Wang, L., Y.C. Tu, T.W. Lian, J.T. Hung, J.H. Yen, and M.J. Wu. 2006. Distinctive antioxidant and anti-inflammatory effects of flavonols. J. Agric. Food Chem. 54, 9798-9804.
28. Wu, Y.L., E.M. Scott, A.L.W. Po, and V.N. Tariq. 1999. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44, 389-392.
29. Yang, X., D.K. Summerhurst, S.F. Koval, C. Ficker, M.L. Smith, and M.A. Bernards. 2001. Isolation of an antimicrobial compound from Impatiens balsamina L. using bioassay-guided fraction. Phytother. Res. 15, 676-680.